Novartis AG (NVSEF) revenue by segment

NVSEFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVS

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30

$146.46+2.56 (+1.78%)

Close on Oct 19, 2026Market cap $279.46BP/E 20.5Yield –

Novartis AG revenue by segment

Novartis does not break out revenue by segment, region or product in the tagged data of its filings for this period type.

See a number that looks wrong?